![]() |
|
|
Vol. 59, Issue 1, 69-75, January 2001
Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio
| |
Abstract |
|---|
|
|
|---|
Activation of endothelial cell integrins inhibits DNA breakage by
diverse agents, including the DNA-damaging agent bleomycin. DNA breaks
activate nuclear poly(ADP-ribose) polymerase (PARP), which regulates
chromatin structure and DNA repair. We determined the role of PARP in
suppression of bleomycin genotoxicity by integrins using wild-type and
PARP knockout mouse lung endothelial cells (MLEC), and the PARP
inhibitor, 3-aminobenzamide (3AB). Activation of
1 integrins by
antibody clustering enhanced the sensitivity of wild-type nuclei to
digestion with micrococcal nuclease and deoxyribonuclease I, indicating
that chromatin structure was altered. 3AB blocked this effect. Knockout
and 3AB-treated wild-type MLEC were hypersensitive to deoxyribonuclease
I compared with wild-type cells, demonstrating that PARP regulates
chromatin structure. Integrin clustering reduced the hypersensitivity
of knockout cells, suggesting additional, PARP-independent mechanisms
that inhibit nuclease interaction with chromatin. Bleomycin caused DNA
breakage in wild-type and knockout MLEC. Breaks were eliminated after
60 min incubation of wild-type cells in drug-free medium, whereas 3AB
or PARP knockout inhibited DNA repair. Integrin clustering protected
wild-type cells from DNA breakage, and 3AB and PARP knockout inhibited
this protection. Bleomycin caused large increases in PARP activity in
wild-type but not knockout MLEC, and integrin clustering inhibited the
activation of PARP. The results indicate that the antigenotoxic effects
of integrin activation require PARP and that integrins alter chromatin
structure by PARP-dependent and -independent mechanisms.
| |
Introduction |
|---|
|
|
|---|
Anticancer
drugs, radiation, and many environmental chemicals are recognized
genotoxins, and any agent that activates oxygen has the potential to
cause DNA breakage (Szabo and Dawson, 1998
). Endothelial cells in the
lung and other organs are common targets of DNA damage, which may lead
to pulmonary and cardiovascular disease. The direct DNA cleaving
antitumor antibiotic bleomycin (BLM), for example, is known to cause
pulmonary fibrosis after a period of acute injury to lung endothelial
and epithelial cells, limiting its use against cancer (Adamson, 1976
).
Inhibition of acute DNA damage in endothelium, or the response to it,
could reduce pulmonary and cardiovascular diseases caused by BLM and other agents.
Previously, we found that activation of integrin cell adhesion
receptors inhibited acute DNA breakage caused by BLM, bacterial endotoxin, and etoposide (Hoyt et al., 1996a
,b
; Hoyt et al., 1997
). Evidence for the role of integrins in promoting endothelial cell survival in the face of different types of stress has accumulated in
recent years (Meredith et al., 1993
; Brooks et al., 1994
; Ilic et al.,
1998
). Integrins are heterodimeric receptors that mediate adhesion of
endothelial cells to extracellular matrix, largely by interaction with
arginine-glycine-aspartate sequences in the matrix proteins. Signal
transduction by integrins activated with peptide ligands or by
clustering with antibodies may mediate their effects (Aplin et al.,
1998
; Ilic et al., 1998
).
BLM, endotoxin, and etoposide cause DNA breakage by different
mechanisms. The topoisomerase II inhibitor, etoposide, causes DNA
breaks in response to stabilization of DNA-topoisomerase complexes in
cell nuclei. Bacterial endotoxin also causes acute, reversible DNA
breakage that greatly precedes apoptosis in endothelial cells. Endotoxin-induced DNA breakage may be caused by reactive oxygen species
and peroxynitrite (Szabo and Dawson, 1998
). The mechanism of BLM is
very well characterized and depends on the ability of the antibiotic to
bind iron and to activate oxygen in the vicinity of DNA (Wu et al.,
1985
). Integrin-mediated protection of endothelial cells from these
diverse agents could result from increased resistance of DNA to
breakage, which may occur if nuclear structure is altered, or from
activation of DNA repair.
The nuclear enzyme poly(ADP-ribose) polymerase (PARP; EC 2.4.2.30)
helps to orchestrate the acute reaction to DNA damage. PARP responds
immediately to genotoxic stress by binding to DNA strand breaks via two
C-terminal zinc fingers. This binding allosterically activates the
enzyme, which uses NAD to synthesize polymers of ADP-ribose (ADPR) on
glutamate residues in its own structure and in other nuclear proteins.
Histones are major targets for modification (Boulikas, 1991
; D'Amours
et al., 1999
). The dynamic balance of poly(ADPR) synthesis by PARP and
its degradation by poly(ADP-ribose) glycohydrolase may govern the final
consequences of PARP activation (D'Amours et al., 1999
).
Topoisomerases and the tumor suppressor p53, which regulate nuclear
function, are among the other targets of PARP that have been identified
in genotoxin-treated cells (Scovassi et al., 1993
; Simbulan-Rosenthal
et al., 1999
; Smith and Grosovsky, 1999
). PARP has a role in DNA
repair, in that such inhibitors as 3-aminobenzamide (3AB) slow the
removal of DNA breaks (Althaus, 1992
). Thus, PARP regulates chromatin
structure and is necessary for DNA repair (D'Amours et al., 1999
).
PARP is activated in a range of pathophysiologic situations, including
oxidant stress (Szabo and Dawson, 1998
). BLM-induced DNA breakage is a
powerful PARP activator, and several studies implicate PARP in
pulmonary fibrosis caused by this drug. The enzyme is activated in vivo
by BLM, and niacin, an inhibitor of PARP and precursor of NAD, reduces
fibrosis (Hussain et al., 1985
; Wang et al., 1990
). Activation of PARP
and depletion of NAD correlate with the sensitivity of lung slices from
different murine strains to the cytotoxicity of BLM. Furthermore, PARP
activation, NAD depletion and cytotoxicity caused by BLM are inhibited
by preincubation of lung slices with 3AB (Hoyt and Lazo, 1992
, 1993
).
Because PARP regulates chromatin structure and DNA repair, we hypothesized that integrin-induced protection of endothelial cells from BLM requires PARP. Here we investigated the ability of integrins to suppress BLM-induced DNA breakage and to alter chromatin in lung endothelial cells from wild-type and PARP knockout mice.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Cell culture media and trypsin were purchased
from Life Technologies (Gaithersburg, MD). Fetal bovine serum
was purchased from Hyclone Laboratories (Logan, UT). BLM, 3AB, goat
anti-rat IgG, goat and rat serum, NAD, and PBS were obtained from Sigma Chemical Co. (St. Louis, MO). Escherichia coli DNA
polymerase I, Micrococcal Nuclease (S1), and bovine serum albumin were
from Roche Diagnostics (Nutley, NJ). Deoxyribonucelase I (DNase
I) was from Cooper Biomedical (Freehold, NJ). Fluorescein-12-dUTP was
purchased from Stratagene (La Jolla, CA). Rat anti-mouse
1 integrin, vascular cell adhesion molecule-1 (VCAM-1), and platelet endothelial cell adhesion molecule (PECAM) were purchased from PharMingen (San Diego, CA), and rabbit anti-poly(ADPR) was obtained from Biomol Research Laboratories, Inc., (Plymouth Meeting, PA). Cy3-conjugated goat anti-rabbit IgG was from Jackson Immunoresearch Laboratories (West Grove, PA).
Cells.
Murine lung microvascular endothelial cells (MLEC)
were isolated from wild-type (+/+) and PARP knockout (
/
) mice (Wang
et al., 1995
) as described previously (Gerritsen et al., 1995
).
Integrin Clustering.
1 integrins were activated with
anti-integrin antibodies as described previously (Hoyt et al., 1996a
).
MLEC were transferred to microscope slides at 80% confluence and
cultured for 24 h. The cells were rinsed and treated 0, 0.1, or 1 µg anti-
1 integrin antibody/ml for 1 h at 4°. Some MLEC
were treated with 1 µg of rat anti-mouse PECAM or VCAM per
milliliter, or preimmune rat serum (1/5000 dilution, which approximates
a 1 µg/ml concentration), rather than anti-integrin antibody. Goat
anti-rat IgG was added to all cells at a concentration of 2 µg/ml and
the temperature was raised to 37° for 2 or 4 h. After
clustering, cells were treated with 0 or 0.2 mg BLM/ml for 45 min. Some
MLEC were rinsed with fresh medium and allowed an additional drug-free
period of 60 min (washout). Where indicated, the PARP-inhibitor, 3AB,
was included at a concentration of 2.5 mM 18 h before clustering
(Hoyt and Lazo, 1992
).
In Situ Nick Translation (ISNT) to Quantify DNA Strand
Breaks.
Cells were washed three times with PBS at 4° after
treatment with BLM. They were fixed with 1% formaldehyde in PBS and
made permeable with 70% ethanol at
20°. DNA breaks were labeled by ISNT with the substitution of fluorescein-12-dUTP (Gorczyca et al.,
1993
; Hoyt et al., 1997
). Cells were then incubated at 37° for 90 min
with ISNT buffer (2.5 mM MgCl2, 50 mM Tris, pH
7.8, 10 mM
-mercaptoethanol, and 10 µg/ml bovine serum albumin)
containing 16 µM each dGTP, dATP, and dCTP, 16 µM
fluorescein-12-dUTP, and 2 U/ml E. coli DNA polymerase. The
labeling was stopped by rinsing with PBS.
Nuclease Digestion.
Relative sensitivity of nuclear DNA to
digestion with exogenous nucleases was used to determine whether
integrins or PARP could alter chromatin structure (von Hippel and
Felsenfeld, 1964
; Hewish and Burgoyne, 1973
). MLEC were fixed with
formaldehyde, permeabilized with ethanol, then rinsed with PBS. For
DNase digestion, cells were rinsed in ISNT buffer and then digested 25 min at room temperature with 0 to 48 U/ml DNase I in ISNT buffer. The
cells were rinsed three times with PBS and subjected to ISNT as
described above. For digestion with micrococcal nuclease (MNase), MLEC
were rinsed in MNase buffer (10 mM Tris, pH 7.4, 1 mM
CaCl2, 2.5 mM MgCl2) and
then digested 25 min at room temperature with 0 to 55 U/ml MNase in
MNase buffer. The cells were then rinsed three times with PBS before
ISNT.
Poly(ADPR) Synthesis In Situ (PARSIS).
MLEC were treated,
rinsed three times with PBS and fixed in acetone at 4°C. Cells were
then rinsed in PARSIS buffer (100 mM Tris, pH 8, 10 mM
MgCl2, 1 mM dithiothreitol), and then incubated 0 to 20 min in PARSIS buffer containing 0 to 200 µM NAD (Iseki, 1987
).
The reaction was stopped by rinsing with PBS. Poly(ADPR) was detected
by fluorescence immunostaining (Kupper et al., 1996
). Cells were
blocked with 10% goat serum in PBS and then incubated with rabbit-anti
poly(ADPR) at 4° for 18 h. After rinsing, Cy3-conjugated goat-anti-rabbit IgG (Fab2') in 10% goat serum in PBS was added for
1 h at 37°. Cells were then rinsed with PBS.
Data Analysis.
An Olympus BX60 fluorescence microscope and
20× objective were used to capture digital images of fluorescein- or
Cy3-labeled MLEC. Fluorescence intensity of nuclei from 100 to 500 cells was determined by image analysis (Scanpro, SPSS Science, Chicago, IL). Data were analyzed by Student's t test or by ANOVA
with Bonferroni correction for multiple comparisons (Snedecor and
Cochran, 1980
).
| |
Results |
|---|
|
|
|---|
Nuclease Sensitivity.
PARP is known to alter chromatin
structure and to facilitate DNA repair. To determine whether integrin
activation or PARP altered chromatin structure, exogenous nucleases
were used to probe the accessibility of DNA (von Hippel and Felsenfeld,
1964
; Hewish and Burgoyne, 1973
). Breaks in DNA were produced
with MNase or DNase I in formaldehyde-fixed +/+ MLEC. MNase is a
calcium-dependent endonuclease that prefers to cut between nucleosomes
in chromatin (Hayes and Lee, 1997
), whereas DNase I cuts more randomly
throughout (Suck, 1997
). Enzyme-generated DNA breaks were detected by
ISNT and fluorescence microscopy.
1 integrin antibody concentration. Activation of
1 integrin for 4 h caused DNase hypersensitivity that increased
as anti-
1 antibody was increased from 0.01 to 1.0 µg/ml (Fig.
2). These results suggest that integrin
activation increased the access of exogenous nucleases to DNA.
|
|
/
MLEC was compared. Figure 3 depicts
the effect of integrin activation on DNase sensitivity in +/+ and
/
MLEC in representative images. The results of image analysis are
presented in Fig. 4. As in the previous
experiments, integrin activation increased the digestion of DNA by
DNase in +/+ cells. In contrast,
/
MLEC were DNase-hypersensitive
compared with +/+ cells, and integrin activation reduced the digestion
of
/
cell DNA. Furthermore, an 18-h preincubation of +/+ cells with
3AB alone moderately increased the sensitivity to DNase. The larger
increase caused by integrin clustering alone was not seen in +/+ cells
when they were treated with both integrin antibody and 3AB.
|
|
BLM-Induced DNA Strand Breakage.
We previously showed that BLM
caused acute, reversible DNA strand breaks that were inhibited by
integrin activation (Hoyt et al., 1997
). DNA strand breaks were
measured here to determine the effect of BLM, 3AB, PARP knockout, and
integrin clustering on breakage and repair (Fig.
5). As expected, BLM caused DNA strand breakage within 45 min. Prior activation of
1 integrin for 4 h
inhibited BLM-induced DNA breakage. The inhibition was specific for the
1 integrin antibody, because neither rat anti-mouse PECAM, VCAM, nor
preimmune rat serum inhibited BLM-induced DNA damage (not shown). DNA
breaks were repaired, as they disappeared after an additional 60-min
incubation in drug-free medium. Preincubation with 2.5 mM 3AB for
18 h did not affect BLM-induced DNA breakage but, as expected, DNA
repair was completely inhibited. The combination of 3AB and integrin
antibody resulted in significant DNA breakage that was less than 3AB
alone and more than
1 clustering alone (not indicated by a symbol).
|
/
MLEC, although it was less than
in +/+ cells. As with +/+ cells treated with 3AB,
/
MLEC did not
effectively repair DNA breaks during washout. In contrast to the
protection of +/+ MLEC,
1-integrin clustering did not inhibit
BLM-induced DNA breakage in
/
cells. This suggested that PARP was
required for the anti-genotoxic action of integrin activation.
Poly(ADP-Ribose) Polymerase (PARP).
PARSIS was developed as a
convenient microscopic method to investigate genotoxic stress and to
characterize knockout cells. Based on a microautoradiographic method
(Iseki, 1987
), acetone-fixed cells were supplemented with various
concentrations of NAD and ADPR polymers were detected by fluorescence
immunostaining (Kupper et al., 1996
). Figure
6 shows the effect of BLM and PARP
knockout on ADPR immunofluorescence. BLM caused a large increase in
poly(ADPR) that was enhanced by NAD added to the in situ reaction with
+/+ cells (Fig. 6, A and D versus C and F) but not
/
cells (Fig. 6,
B and E). Inclusion of 3AB in the in situ reaction abolished labeling
in +/+ cells treated with BLM and incubated with 20 µM NAD (Fig. 6G).
Image analysis of BLM-treated +/+ MLEC showed that poly(ADPR) levels
were dependent on increasing concentrations of NAD and maximal
incorporation was seen at 10 min in +/+ cells (Fig.
7). Based on these results, a 10-min
reaction with 0 to 200 µM NAD was used to assess the effects of BLM,
1-integrin clustering, and 3AB on PARP activity. BLM significantly
increased the level of poly(ADPR) detected after in vitro incubation of fixed cells with 0, 2, 20, and 200 µM NAD compared with cells that
were not treated with BLM (Fig. 8).
/
MLEC synthesized far less poly(ADPR) than +/+ MLEC in all conditions. A
small BLM-dependent increase in poly(ADPR) was seen in
/
cells
incubated with 200 µM NAD, however.
|
|
|
1-integrin clustering for 4 h in +/+ MLEC blocked both the
BLM-stimulated basal polymer level and the BLM-stimulated in vitro synthesis in the presence of 20 µM NAD (Fig.
9). Preincubation of +/+ MLEC with 2.5 mM
3AB for 18 h alone, or followed by integrin clustering, also
prevented increases in poly(ADPR) caused by BLM.
|
| |
Discussion |
|---|
|
|
|---|
Integrin cell-adhesion receptor activation inhibits acute DNA
breakage caused by a variety of unrelated agents (Hoyt et al., 1996a
,b
;
Hoyt et al., 1997
). Integrins may protect cells by multiple mechanisms
that are specific to each agent. Alternatively, one or a few general
mechanisms could account for broad protection by integrin activation.
Integrin activation could affect cell nuclei, enhancing repair or
making DNA resistant to damage. Here we demonstrated for the first time
that integrin activation altered the structure of MLEC chromatin, as
indicated by changes in sensitivity to nucleases (von Hippel and
Felsenfeld, 1964
; Hewish and Burgoyne, 1973
). The sensitization may
have resulted from dissociation or movement of proteins that restricted
the access of nucleases to DNA. Although the exact mechanism for
altered nuclease sensitivity is not fully understood, we can conclude
that integrin activation affected the MLEC nucleus. A fundamental
change in the nucleus could affect DNA breakage or repair in response
to many agents.
It is possible that integrins reduce the cellular accumulation of
chemicals. However, altered transport did not account for integrin-induced resistance of myeloma cells to doxorubicin and melphalan (Damiano et al., 1999
). The effect of integrins on transport in MLEC has not been investigated.
The nuclear enzyme, PARP, is activated by DNA strand breaks and it
alters chromatin structure by modification of nuclear proteins (Das and
Kanungo, 1986a
,b
; Boulikas, 1991
; D'Amours et al., 1999
). Thus,
inhibition or genetic deletion of PARP should affect MLEC nuclei.
Indeed, 3AB increased DNase digestion of +/+ cells, and knockout of
PARP rendered
/
cells more sensitive to digestion with DNase than
wild-type MLEC (Fig. 4).
The critical role of PARP in DNA repair was confirmed by the
observation that BLM-induced DNA breaks were not repaired in
/
cells or in +/+ cells treated with 3AB (Fig. 5). This result was
expected from previous studies by many others (D'Amours et al., 1999
).
Furthermore, integrin clustering did not inhibit BLM-induced breakage
in
/
or 3AB-treated cells as greatly as in +/+ cells. Thus,
integrin-mediated protection from BLM requires PARP.
We measured basal and in vitro synthesized poly(ADPR) to determine the
effect of BLM and integrin activation on PARP. Polymerization of ADPR
is normally rapid, and begins within minutes of DNA damage. The
majority of cellular NAD may even be consumed by the reaction. Degradation of poly(ADPR) by glycohydrolase is also immediate, so that
a transient modification of nuclear proteins is seen (D'Amours et al.,
1999
). Consistent with these facts was our finding that poly(ADPR) was
low in control MLEC and that BLM significantly increased the basal
polymer level in +/+ cells (Figs. 8 and 9). Furthermore, in vitro
reaction with 20 to 200 µM NAD in fixed +/+ cells greatly increased
poly(ADPR) content. Thus, basal poly(ADPR) presumably reflects the
steady state condition in cells, whereas reaction with NAD in vitro,
where initial velocity conditions outweigh degradation of poly(ADPR),
reflects the activation state of PARP.
Integrin clustering inhibited the increase in basal poly(ADPR) and PARP activation by BLM in +/+ MLEC (Fig. 9). Inhibition of BLM-induced DNA breakage as seen in Fig. 5 may account for this, as PARP would not be activated in the absence of DNA breaks.
+/+ and
/
MLEC differed greatly in PARP activation by BLM.
/
cells were incapable of synthesizing the large amounts of poly(ADPR)
seen in wild-type cells. Nevertheless, there was a small but
significant signal in BLM-treated
/
MLEC incubated with the highest
level of NAD (200 µM, Fig. 8). Other minor poly(ADP-ribose) polymerases that are activated by DNA-damaging agents have been discovered since the generation of PARP knockout mice. The majority of
this residual PARP is sensitive to inhibition by benzamide (Shieh et
al., 1998
). These minor isozymes may account for the low-level PARP
activation seen in these cells, in which only PARP-1 has been deleted.
Although the activity of alternative poly(ADP-ribose) polymerases is
low compared with the major enzyme, they could have unrecognized
biological functions (Shieh et al., 1998
; Smith et al., 1998
; D'Amours
et al., 1999
).
It was interesting that in wild-type MLEC 3AB prevented the activation
of PARP even though DNA breaks were present, and repair was blocked
(Fig. 5). We observed a similar action of 3AB on PARP in nuclei
isolated from BLM-treated lung slices using radiolabeled NAD as the
reaction substrate (Hoyt and Lazo, 1992
). 3AB is a competitive
inhibitor of PARP that presumably blocks poly(ADPR) synthesis in living
MLEC during exposure to BLM (Purnell and Whish, 1980
). Prevention of
enzyme activation by the competitive inhibitor cannot be explained if
3AB were actually washed out before the start of the in vitro PARSIS
reaction. However, 3AB may have altered nuclei during the incubation
with live cells such that PARP could not be activated by BLM, despite
the presence of DNA breaks (Fig. 5). 3AB did increase the sensitivity
of wild-type nuclei to DNase I, indicating that there was a change in
chromatin structure (Fig. 4). We speculate that PARP probably bound to
DNA breaks in BLM-treated cells, although polymerase activity was
blocked by the competitive action of 3AB. This could have affected
other systems regulated by PARP, such as DNA repair complexes,
topoisomerases, and p53, that would otherwise operate in an environment
of massive poly(ADP-ribosyl)ation after DNA breakage. This situation
may have limited the activation of PARP detected in vitro in fixed
cells despite the presence of DNA breaks.
Integrin clustering affected chromatin differently in wild-type and
knockout MLEC. In contrast to +/+ cells, nuclei from
/
cells
initially had a high level of DNase sensitivity, which was lowered by
integrin clustering (Fig. 4). These data suggest that integrins acted
in knockout cells by a PARP-independent mechanism to restrict the
accessibility of DNA to nucleases (Fig.
10), whereas PARP-dependent actions
(i.e., those seen in wild-type cells) had the opposite effect, opening
chromatin to digestion with nucleases. PARP-independent actions of
integrins likely involve other chromatin regulatory processes.
Phosphorylation or acetylation of nuclear proteins or the methylation
of DNA may be regulated by integrins, for example.
|
We propose that a balance exists between integrin-induced,
PARP-dependent elevation, and PARP-independent suppression of nuclease sensitivity (Fig. 10). In the absence of PARP, clustering cannot further enhance digestion, leaving actions that lower nuclease sensitivity unopposed. The ability of integrin clustering to inhibit damage by BLM was PARP-dependent (Fig. 5). Our model proposes that
PARP-dependent opening of chromatin structure by
1-integrin activation could contribute to this inhibition of damage. The opening
of chromatin by integrin clustering in wild-type cells could inhibit
cleavage of DNA by BLM, although access of the drug to DNA would be
expected to increase, as for DNase. It is more likely that DNA repair
was increased in wild-type MLEC, limiting the breakage detected after
BLM exposure.
An apparent paradox is that integrin clustering did not inhibit BLM-induced DNA breakage in PARP knockout cells, despite reducing nuclease sensitivity from its initial high level. Because BLM is a much smaller molecule than DNase, this PARP-independent chromatin closing action may not have been be sufficient to limit cleavage by the drug. Integrin clustering may be less effective at reducing damage by BLM in PARP knockouts if integrin engagement normally enhances PARP-dependent repair, which is absent in those cells (Fig. 5). We are currently examining this possibility. Although the mechanism remains to be determined, it is clear that integrin clustering altered chromatin structure and that PARP modulated the nuclear response.
In conclusion, integrin activation inhibited BLM-induced DNA breakage and PARP activation in wild-type MLEC, despite increasing the access of DNA to nucleases. 3AB and PARP knockout reduced the protection from BLM afforded by integrin clustering. Integrin clustering caused a PARP-independent suppression of nuclease sensitivity in the knockout cells. The results demonstrate that the antigenotoxic and chromatin-modulating actions of integrins are sensitive to PARP.
| |
Acknowledgments |
|---|
We appreciate the assistance of Leah C. Arnold and the mice provided by Dr. Csaba Szabo (Inotek Corporation, Beverly, MA).
| |
Footnotes |
|---|
Received March 6, 2000; Accepted October 11, 2000
This work was supported by an award from the American Heart Association, Ohio Valley Affiliate (C.B.J.), American Lung Association Career Investigator Award CI-009N (D.G.H.), and by National Institutes of Health Grants HL56018 and P30-CA16058.
Send reprint requests to: Dale G. Hoyt, Ph.D., The Ohio State University, Division of Pharmacology, College of Pharmacy, 500 West Twelfth Avenue, Columbus, Ohio. E-mail: hoyt-27{at}osu.edu
| |
Abbreviations |
|---|
BLM, bleomycin; PARP, poly(ADP-ribose) polymerase; ADPR, ADP-ribose; 3AB, 3-aminobenzamide; DNase, deoxyribonuclease; VCAM-1, vascular cell adhesion molecule-1; PECAM, platelet endothelial cell adhesion molecule; MLEC, mouse lung endothelial cells; ISNT, in situ nick translation; MNase, micrococcal nuclease; PARSIS, poly(ADPR) synthesis in situ.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. L. Rose, K. C. Reeves, R. I. Likhotvorik, and D. G. Hoyt Base Excision Repair Proteins Are Required for Integrin-Mediated Suppression of Bleomycin-Induced DNA Breakage in Murine Lung Endothelial Cells J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 318 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zaniolo, M.-E. Gingras, M. Audette, and S. L. Guerin Expression of the Gene Encoding Poly(ADP-ribose) Polymerase-1 Is Modulated by Fibronectin during Corneal Wound Healing. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4199 - 4210. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, H. Conner, T. Kobayashi, H. Kim, F. Wen, S. Abe, Q. Fang, X. Wang, M. Hashimoto, P. Bitterman, et al. Cigarette Smoke Extract Induces DNA Damage but Not Apoptosis in Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., August 1, 2005; 33(2): 121 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Rose, H. Huang, S. F. Wray, and D. G. Hoyt Integrin Engagement Increases Histone H3 Acetylation and Reduces Histone H1 Association with DNA in Murine Lung Endothelial Cells Mol. Pharmacol., August 1, 2005; 68(2): 439 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Marchion, E. Bicaku, A. I. Daud, D. M. Sullivan, and P. N. Munster Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins Cancer Res., May 1, 2005; 65(9): 3815 - 3822. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||